Innova Captab Limited (BOM:544067)
India flag India · Delayed Price · Currency is INR
911.65
+7.20 (0.80%)
At close: Apr 17, 2025

Innova Captab Company Description

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

The company provides contract development and manufacturing organization services to Indian pharmaceutical companies.

It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals.

The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites.

Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Innova Captab Limited
Country India
Founded 2005
Industry Pharmaceutical Preparations
Employees 1,600
CEO Vinay Lohariwala

Contact Details

Address:
SCO No. 301, 2nd Floor
Panchkula, Maharashtra 134109
India
Phone 91 17 2419 4500
Website innovacaptab.com

Stock Details

Ticker Symbol 544067
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Vinay Lohariwala Chief Executive Officer
Lokesh Bhasin Chief Financial Officer